Study Summary
This trial will compare the efficacy of oral versus intravenous iron therapy for the treatment of iron deficiency anemia in the post-bariatric surgical patient.
- Iron-Deficiency Anemia
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 3 Secondary · Reporting Duration: 6 weeks
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
IV Iron
1 of 2
Oral Iron
1 of 2
Active Control
104 Total Participants · 2 Treatment Groups
Primary Treatment: IV Iron · No Placebo Group · Phase 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are volunteers still being sought for this clinical trial?
"This is an active recruitment trial, according to the information available on clinicaltrials.gov. The study was posted on 2/27/2020, with the most recent update taking place on 2/16/2022." - Anonymous Online Contributor
Could you please explain what intravenous iron is commonly used to treat?
"IV Iron is frequently used to remedy a vitamin a deficiency. Additionally, it is sometimes used to mitigate the effects of anemia, vitamin deficiency, and catarrh." - Anonymous Online Contributor
Could you please give an estimate of how many people are participating in this clinical trial?
"That is correct, the clinicaltrials.gov website does show that this study is actively recruiting patients. This specific study was posted on February 27th, 2020 and was updated as recently as February 16th, 2022. Currently, they are looking to enroll 104 participants from a single site." - Anonymous Online Contributor
When was the last time IV Iron was cleared by the FDA?
"IV Iron has been found to be safe in Phase 3 trials, meaning that it has undergone multiple rounds of testing with positive results." - Anonymous Online Contributor